|
 One of Southeast Asia’s most anticipated medical and healthcare events, The Health Industry Series - ASEAN (tHIS ASEAN 2025) will make its debut next week at the Kuala Lumpur Convention Centre from 9–11 June. Organised by Reed Sinopharm Exhibitions in partnership with the Association of Private Hospitals Malaysia (APHM), the event will feature over 200 exhibitors and an expected 5,000+ healthcare professionals, promising a dynamic exchange of innovation, insight, and investment opportunities across the region’s fast-growing health sector.
Unique in the region, tHIS ASEAN serves as a dedicated China-to-ASEAN gateway—bringing curated, credentialed suppliers into direct contact with hospital leaders, procurement teams, distributors, and clinicians seeking reliable and relevant partnerships.
“This inaugural edition marks a strategic leap forward for China’s healthcare industry, as tHIS ASEAN 2025 represents one of the largest showcases of Chinese medical advancements in the region, and reflects Southeast Asia’s growing importance as a hub for healthcare innovation,” said James Wang, director of International Business, Reed Sinopharm Exhibitions.
Building on the global reputation of RSE’s flagship exhibitions— CMEF, PHARMCHINA, CRS, CHCC and ICMD —tHIS ASEAN convenes innovators, healthcare professionals, and policymakers to spotlight cutting-edge technologies and to unlock opportunities across medical equipment, pharmaceuticals, rehabilitation, hospital construction, and component manufacturing. The event will be co-located with the APHM International Healthcare Conference & Exhibition.
The exhibition—spanning over 5,000 square meters—is grouped into five key categories, reflecting the current and future engines of growth in ASEAN’s healthcare market like medical equipment: diagnostic tools, surgical robots, and next-gen imaging technologies, Pharmaceuticals: Innovative drugs, OTC products, and biotech advancements, rehabilitation: robotic exoskeletons, assistive technologies, and elderly care solutions, hospital construction: smart infrastructure, facility planning, and sustainable design and component manufacturing & Design: Precision parts, materials, and R&D solutions supporting product development.
Amid rising pressure on healthcare budgets, tHIS ASEAN enables buyers to explore cost-effective, regulation-compliant technologies—without sacrificing quality, certification, or scale. The event will feature a large-scale delegation of Chinese manufacturers offering reliable, high-performance solutions built for efficiency and long-term value.
Visitors will have the opportunity to engage directly with suppliers whose products have gained traction in global markets. Notable companies include Sinopharm Group, Mindray, United Imaging, and Gaomai Pharma, among others—providing direct access to next-generation technologies that are both competitive and credible.
Complementing the exhibition is a robust conference programme tackling critical themes across innovation, regulation, infrastructure, and cross-border collaboration.
On June 9, Conference themed ‘Innovative Technologies Shaping the Future of Medical Devices’ will discuss ‘How AI is transforming smart diagnostics, surgical robotics, and real-time monitoring, with insights from clinicians, manufacturers, and regulators’. The same day Conference themed ‘Pharmaceutical Innovation Products and Technologies Future Trends’ will discuss ‘Exploring R&D, registration, and cross-border commercialization strategies for innovative pharma products between China and ASEAN’.
On June 10, Conference themed ‘ASEAN Rehabilitation and Elderly Care Industry’ will discuss ‘Showcasing rehabilitation robotics and aged care innovations, with a focus on joint development across Southeast Asia’. The same day Conference themed ‘China-ASEAN Pharmaceutical Market Cooperation’ will discuss ‘Addressing regulatory harmonization, market access, and regional supply chain resilience’. The same day Conference themed ‘Hospital of the Future: Innovation & Cooperation’ will discuss ‘Designing smart, efficient hospitals—covering construction models, upgrades, and sustainability in ASEAN infrastructure’.
On June 11, Conference themed ‘Expanding into ASEAN: Regulations, Trends, and Cultural Considerations’ will discuss ‘Offering practical guidance on entering ASEAN markets, with regulatory insight and strategies tailored to the region’s cultural diversity.’
Speakers include regional healthcare policymakers, tech entrepreneurs, and clinical experts who will share actionable insights on the future of the industry, and transfer knowledge such as learnings from hospital construction case studies. These complimentary sessions promise to spark meaningful dialogue and chart the course for ASEAN’s next chapter in healthcare.
Industry professionals are invited to experience the region’s most comprehensive healthcare showcase—from breakthrough innovations to hands-on demonstrations and expert-led conferences. Whether you’re seeking new technologies, partnerships, or insights, tHIS ASEAN 2025 offers unparalleled opportunities to connect and discover.
The Health Industry Series - ASEAN (tHIS ASEAN) is a premier healthcare exhibition and conference platform in Southeast Asia, organised by Reed Sinopharm Exhibitions. As a strategic, regional extension of globally recognised exhibitions—CMEF (China International Medical Equipment Fair), PHARMCHINA, CRS (China International Rehabilitation and Personal Health Show) , CHCC (China Hospital Construction Conference), and ICMD (International Component Manufacturing and Design Show—it brings together global innovators, healthcare professionals, and policymakers to showcase cutting-edge medical technologies and explore opportunities across the medical equipment, pharmaceutical, rehabilitation, hospital construction, and component manufacturing sectors.
Held in partnership with the Association of Private Hospitals of Malaysia (APHM), tHIS ASEAN serves as a dynamic hub for industry collaboration, market access, and healthcare advancement in the region.
Reed Sinopharm Exhibitions Co., Ltd. is one of the most renowned event organisers dedicated to health, beauty, wellness and education sectors in China. The company is a joint venture between Sinopharm - the largest medical and healthcare group in China, and RX Global - a leading global event organiser. Reed Sinopharm runs a portfolio of 38 highly recognized events and plays host to nearly 21,000 local and global exhibitors from over 150 countries and regions, along with more than 1,200 conferences and academic seminars. Reed Sinopharm's events cover a total of 1,300,000 sqm in exhibition space and welcome over 750,000 trade visitors worldwide every year. Through its international events, it offers innovative solutions to help customers build their businesses, explore opportunities and access key markets.
|